封面
市场调查报告书
商品编码
1946572

2026年全球多重PCR检测市场报告

Multiplex PCR Assays Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,多重PCR检测市场发展迅速,预计将从2025年的17亿美元成长到2026年的19.3亿美元,复合年增长率达13.4%。过去几年的增长可能归因于多种因素,包括感染疾病的增加、分子诊断的日益普及、单重PCR检测的局限性、对快速诊断结果日益增长的需求以及诊断实验室基础设施的扩建。

预计未来几年多重PCR检测市场规模将快速成长,到2030年将达到31.7亿美元,复合年增长率(CAGR)为13.2%。预测期内的增长可归因于对疾病早期检测的日益重视、对综合诊断解决方案需求的不断增长、个性化医疗方法的推广、分子诊断投资的增加以及多重检测在常规检测中的应用日益广泛。预测期内的主要趋势包括:感染疾病多重检测的应用日益普及、对高通量诊断检测的需求不断增长、综合征检测组合的使用日益增多、多重PCR在临床诊断中的应用不断扩展,以及对高性价比多靶点检测方法的日益青睐。

预计对诊断检测日益增长的需求将推动多重PCR检测市场的扩张。诊断检测是指用于确定患者是否存在某种疾病或病症的程序或测试。随着癌症和糖尿病等慢性疾病的日益普遍,早期准确诊断对于有效管理至关重要。此外,对预防性医疗保健的重视也推动了常规检测,以便及早发现潜在的健康问题。多重PCR检测可以同时检测和分析单一检体中的多种病原体和遗传标记,从而提高诊断检测的效率和全面性。例如,根据英国国家医疗服务体系(NHS)2024年7月发布的公告,2023年的诊断活动已超过疫情前水平,2024年5月的检测数量比上年同期增长了21%。此外,2024年5月共进行了240万次诊断检测。预计对诊断检测日益增长的需求将推动多重PCR检测市场的成长。

多重PCR检测市场的主要企业正致力于整合自动化技术,例如新一代定量PCR (qPCR) 系统,以实现精准灵活的核酸定量,从而应用于先进的临床诊断和公共卫生领域。新一代qPCR系统能够同时高通量、精准地侦测多个标靶,有助于提高诊断的准确性和效率。例如,总部位于瑞士的诊断系统解决方案供应商罗氏诊断于2023年11月发布了LightCycler PRO系统。这款新一代qPCR平台具有更佳的温度均匀性、先进的软体,并相容于超过200种LightMix Modular和60种CE-IVD检测方法,能够以高通量精准地同时检测多个标靶。此次发布标誌着多重PCR检测市场正式引入自动化技术,并推动了临床诊断和公共卫生领域的进步。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球多重PCR检测市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧和自主智能
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 感染疾病多重检测技术的日益普及
    • 对高通量诊断检测的需求不断增长
    • 扩大综合征检测组合的应用
    • 扩大多重PCR在临床诊断的应用
    • 人们越来越倾向选择经济高效的多标靶检测方法。

第五章 终端用户产业市场分析

  • 生物製药公司
  • 临床研究所
  • 学术研究机构
  • 诊断中心
  • 标准与检验组织

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球多重PCR检测市场:PESTEL分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 全球多重PCR检测市场规模、对比及成长率分析
  • 全球多重PCR检测市场表现:规模与成长,2020-2025年
  • 全球多重PCR检测市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场规模(TAM)

第九章 市场细分

  • 按检测类型
  • 平面检测、以微珠为基础的检测
  • 按产品和服务分类
  • 耗材、设备、软体和服务
  • 透过使用
  • 疾病诊断、研究与发展及其他用途
  • 最终用户
  • 生物製药公司、临床研究机构、学术研究机构、诊断中心和其他最终用户
  • 按类型细分:平面测定
  • 基于微阵列的检测方法,基于DNA晶片的检测方法
  • 按类型细分:以微珠为基础的检测
  • Luminex Xmap 检测、Magpix 检测、基于流式细胞技术的轮胎边缘检测

第十章 区域与国家分析

  • 全球多重PCR检测市场:区域分析、预测及成长,2020-2025年、2025-2030年预测、2035年预测
  • 全球多重PCR检测市场:依国家划分,实际结果与预测,2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 多重PCR检测市场:竞争格局及市场占有率(2024年)
  • 多重PCR检测市场:公司估值矩阵
  • 多重PCR检测市场:公司概况
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc
    • Abbott Laboratories
    • Danaher Corporation
    • Merck KGaA

第37章:其他领先和创新企业

  • Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年多重PCR检测市场:提供新机会的国家
  • 2030年多重PCR检测市场:新兴细分市场机会
  • 2030年多重PCR检测市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MMPAC01_G26Q1

Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.

The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.

Tariffs have influenced the multiplex pcr assays market by increasing costs for imported reagents, enzymes, consumables, and analytical instruments. These impacts are most evident in north america and asia-pacific, where laboratories depend heavily on globally sourced molecular diagnostics components. Elevated costs have affected pricing and procurement decisions for diagnostic centers and research institutes. On the positive side, tariffs have encouraged local manufacturing, regional reagent production, and supply chain diversification, strengthening long-term market resilience.

The multiplex pcr assays market research report is one of a series of new reports from The Business Research Company that provides multiplex pcr assays market statistics, including multiplex pcr assays industry global market size, regional shares, competitors with a multiplex pcr assays market share, detailed multiplex pcr assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex pcr assays industry. This multiplex pcr assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.7 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising burden of infectious diseases, increasing adoption of molecular diagnostics, limitations of singleplex pcr testing, growing demand for rapid diagnostic results, expansion of diagnostic laboratory infrastructure.

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.

The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.

Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.

In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation

North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex PCR Assays Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Assay Type: Planar Assay; Bead Based Assay
  • 2) By Product And Services: Consumables; Instruments; Software And Services
  • 3) By Application: Disease Diagnosis; Research And Development; Other Applications
  • 4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays
  • 2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc; PerkinElmer Inc; Bio-Rad Laboratories Inc; QIAGEN NV; Tecan Group Ltd; DiaSorin SpA; Bio-Techne Corporation; Promega Corporation; Randox Laboratories Ltd; BioFire Diagnostics Inc; Seegene Inc; NanoString Technologies; Standard BioTools Inc; Agena Bioscience; Fluidigm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Multiplex PCR Assays Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Multiplex PCR Assays Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Multiplex PCR Assays Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Multiplex PCR Assays Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex Testing For Infectious Diseases
    • 4.2.2 Increasing Demand For High-Throughput Diagnostic Assays
    • 4.2.3 Growing Use Of Syndromic Testing Panels
    • 4.2.4 Expansion Of Multiplex PCR In Clinical Diagnostics
    • 4.2.5 Increasing Preference For Cost-Effective Multi-Target Assays

5. Multiplex PCR Assays Market Analysis Of End Use Industries

  • 5.1 Biopharmaceutical Companies
  • 5.2 Clinical Research Organizations
  • 5.3 Academic Research Institutes
  • 5.4 Diagnostic Centers
  • 5.5 Reference Laboratories

6. Multiplex PCR Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Multiplex PCR Assays Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Multiplex PCR Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Multiplex PCR Assays Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Multiplex PCR Assays Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Multiplex PCR Assays Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Multiplex PCR Assays Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Multiplex PCR Assays Market Segmentation

  • 9.1. Global Multiplex PCR Assays Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Planar Assay, Bead Based Assay
  • 9.2. Global Multiplex PCR Assays Market, Segmentation By Product And Services, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Instruments, Software And Services
  • 9.3. Global Multiplex PCR Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disease Diagnosis, Research And Development, Other Applications
  • 9.4. Global Multiplex PCR Assays Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
  • 9.5. Global Multiplex PCR Assays Market, Sub-Segmentation Of Planar Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microarray-Based Assays, Dna Chip-Based Assays
  • 9.6. Global Multiplex PCR Assays Market, Sub-Segmentation Of Bead Based Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

10. Multiplex PCR Assays Market Regional And Country Analysis

  • 10.1. Global Multiplex PCR Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Multiplex PCR Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Multiplex PCR Assays Market

  • 11.1. Asia-Pacific Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Multiplex PCR Assays Market

  • 12.1. China Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Multiplex PCR Assays Market

  • 13.1. India Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Multiplex PCR Assays Market

  • 14.1. Japan Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Multiplex PCR Assays Market

  • 15.1. Australia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Multiplex PCR Assays Market

  • 16.1. Indonesia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Multiplex PCR Assays Market

  • 17.1. South Korea Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Multiplex PCR Assays Market

  • 18.1. Taiwan Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Multiplex PCR Assays Market

  • 19.1. South East Asia Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Multiplex PCR Assays Market

  • 20.1. Western Europe Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Multiplex PCR Assays Market

  • 21.1. UK Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Multiplex PCR Assays Market

  • 22.1. Germany Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Multiplex PCR Assays Market

  • 23.1. France Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Multiplex PCR Assays Market

  • 24.1. Italy Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Multiplex PCR Assays Market

  • 25.1. Spain Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Multiplex PCR Assays Market

  • 26.1. Eastern Europe Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Multiplex PCR Assays Market

  • 27.1. Russia Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Multiplex PCR Assays Market

  • 28.1. North America Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Multiplex PCR Assays Market

  • 29.1. USA Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Multiplex PCR Assays Market

  • 30.1. Canada Multiplex PCR Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Multiplex PCR Assays Market

  • 31.1. South America Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Multiplex PCR Assays Market

  • 32.1. Brazil Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Multiplex PCR Assays Market

  • 33.1. Middle East Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Multiplex PCR Assays Market

  • 34.1. Africa Multiplex PCR Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Multiplex PCR Assays Market, Segmentation By Assay Type, Segmentation By Product And Services, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Multiplex PCR Assays Market Regulatory and Investment Landscape

36. Multiplex PCR Assays Market Competitive Landscape And Company Profiles

  • 36.1. Multiplex PCR Assays Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Multiplex PCR Assays Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Multiplex PCR Assays Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Multiplex PCR Assays Market Other Major And Innovative Companies

  • Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc

38. Global Multiplex PCR Assays Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Multiplex PCR Assays Market

40. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies

  • 40.1 Multiplex PCR Assays Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Multiplex PCR Assays Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Multiplex PCR Assays Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer